Jeffrey White - Amedica Independent Director
Director
Mr. Jeffrey S. White is Independent Director of Amedica Corporationrationration. Since July 2014 Mr. White has served as President, Liventa Bioscience, a company which offers specialty amniotic tissue allografts for use in surgical and wound care applications he has also served on the Board of Liventa Bioscience since January 2014. Since January 2013, Mr. White has served as Principal at Medtech Advisory Group LLC, a firm he founded that advises early and midstage medical technology firms. Mr. White is currently a director of Residency Select LLC, a company which offers psychometric assessment, training and compliance products to medical and surgical residency programs. From May 2006 to December 2012 he served as Global Director of Business Development for Synthes Inc., a global orthopedic firm that was acquired by Johnson and Johnson in 2012. Mr. White has served as Chief Executive Officer and cofounder of several startup surgical device firms and has previously held executive level positions at RichardAllan Medical Industries Inc., a medical device manufacturer, which was acquired by Urohealth Systems Inc. and United States Surgical Corporationrationration, unit of Covidien plc since 2014.
| Age | 60 |
| Tenure | 10 years |
| Phone | 801-839-3500 |
| Web | http://www.amedica.com |
Jeffrey White Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jeffrey White against Amedica stock is an integral part of due diligence when investing in Amedica. Jeffrey White insider activity provides valuable insight into whether Amedica is net buyers or sellers over its current business cycle. Note, Amedica insiders must abide by specific rules, including filing SEC forms every time they buy or sell Amedica'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jeffrey White few days ago Disposition of 5338 shares by Jeffrey White of Sportsmans at 3.43 subject to Rule 16b-3 | ||
Jeffrey White over a week ago Disposition of 5338 shares by Jeffrey White of Sportsmans at 3.43 subject to Rule 16b-3 | ||
Jeffrey White over a month ago Disposition of 319 shares by Jeffrey White of Sportsmans at 3.16 subject to Rule 16b-3 | ||
Jeffrey White over a month ago Disposition of 3346 shares by Jeffrey White of Sportsmans at 3.16 subject to Rule 16b-3 |
Amedica Management Efficiency
The company has return on total asset (ROA) of (20.87) % which means that it has lost $20.87 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (108.79) %, meaning that it created substantial loss on money invested by shareholders. Amedica's management efficiency ratios could be used to measure how well Amedica manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 2.48 M in liabilities with Debt to Equity (D/E) ratio of 21.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amedica has a current ratio of 1.09, suggesting that it is in a questionable position to pay out its financial obligations when due. Debt can assist Amedica until it has trouble settling it off, either with new capital or with free cash flow. So, Amedica's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amedica sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amedica to invest in growth at high rates of return. When we think about Amedica's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Hisashi Hasegawa | HUTCHMED DRC | N/A | |
| Karen Ferrante | HUTCHMED DRC | 58 | |
| Daniel Stauber | Hawkins | 62 | |
| Michael Berendt | Waters | 71 | |
| Takuro Sato | HUTCHMED DRC | N/A | |
| Christopher Huang | HUTCHMED DRC | 62 | |
| Michael Howell | HUTCHMED DRC | 67 | |
| BSE CS | HUTCHMED DRC | 72 | |
| Linda Baddour | Waters | 62 | |
| Christopher Nash | HUTCHMED DRC | 56 | |
| Tetsuo Katsurayama | HUTCHMED DRC | 58 | |
| Caspar Tudor | Waters | N/A | |
| Duane Jergenson | Hawkins | 70 | |
| Jeffrey Wright | Hawkins | 54 | |
| Gary Hendrickson | Waters | 64 | |
| Shigeru Azuhata | HUTCHMED DRC | 64 | |
| Shigeru Endo | HUTCHMED DRC | 81 | |
| Edward Conard | Waters | 63 | |
| Daryl Skaar | Hawkins | 74 | |
| Kotaro Hirano | HUTCHMED DRC | 55 | |
| Dan Eldar | HUTCHMED DRC | 61 | |
Management Performance
| Return On Equity | -108.79 | |||
| Return On Asset | -20.87 |
Amedica Leadership Team
Elected by the shareholders, the Amedica's board of directors comprises two types of representatives: Amedica inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amedica. The board's role is to monitor Amedica's management team and ensure that shareholders' interests are well served. Amedica's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amedica's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mike Houston, VP of Commercialization and Communications | ||
| Jeffrey White, Independent Director | ||
| David Truetzel, Independent Director | ||
| Ty Lombardi, Principal Accounting Officer and VP of Fin. | ||
| Sonny Bal, Chairman of the Board and Presidentident, CEO | ||
| Dana Lyons, Vice President - Sales and Marketing | ||
| Bryan McEntire, CTO | ||
| Eric Stookey, Independent Director |
Amedica Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amedica a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -108.79 | |||
| Return On Asset | -20.87 | |||
| Profit Margin | (131.93) % | |||
| Operating Margin | (77.73) % | |||
| Current Valuation | (2.67 M) | |||
| Shares Outstanding | 11.87 M | |||
| Shares Owned By Insiders | 3.62 % | |||
| Shares Owned By Institutions | 5.20 % | |||
| Number Of Shares Shorted | 827.1 K | |||
| Price To Earning | (0.23) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amedica in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amedica's short interest history, or implied volatility extrapolated from Amedica options trading.
Pair Trading with Amedica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amedica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amedica will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Alphabet could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alphabet when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alphabet - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alphabet Inc Class C to buy it.
The correlation of Alphabet is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alphabet moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alphabet Class C moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alphabet can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Amedica information on this page should be used as a complementary analysis to other Amedica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Amedica Stock
If you are still planning to invest in Amedica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amedica's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |